HALT Fentanyl Act Halt All Lethal Trafficking of Fentanyl Act
Impact
If passed, SB331 will modify federal laws pertaining to the manufacturing and research of fentanyl-related substances, thereby tightening regulations on substances that could be misused. Notably, the bill proposes a transparency measure which requires the Attorney General to disclose specific processes when evaluating applications for research on controlled substances, ensuring that practitioners remain informed about the requirements they must satisfy. This legislation emphasizes the need for rapid and efficient action against the development and distribution of dangerous drugs, thereby aiming to protect public health while promoting medically supervised research that could lead to effective treatments and solutions.
Summary
Senate Bill 331, titled the "Halt All Lethal Trafficking of Fentanyl Act" (HALT Fentanyl Act), seeks to amend the Controlled Substances Act to enhance the scheduling of fentanyl-related substances. The bill aims to streamline the registration process for practitioners conducting research on these substances and to ensure that authorities remain vigilant against the illicit trafficking of fentanyl derivatives, which pose significant public health risks. By classifying a broader range of substances related to fentanyl under stringent controls, the bill intends to close loopholes that allow for the production and distribution of potent synthetic opioids that have contributed to the opioid crisis across the nation.
Sentiment
The general sentiment surrounding SB331 reflects a bipartisan consensus on the urgency of addressing the fentanyl crisis. Supporters, including many public health advocates and lawmakers, regard the bill as a necessary step towards improving drug safety and enhancing law enforcement capabilities to combat drug trafficking. Conversely, concerns have been raised by some members regarding the potential burdens placed on researchers, as the bill could impose new regulatory hurdles that may limit scientific exploration into the therapeutic uses of certain controlled substances. The discussions suggest a balancing act between ensuring public safety and fostering medical research.
Contention
A point of contention arises from the need to ensure that the regulations do not inhibit legitimate research and innovation in medical science. While tightening controls on fentanyl-related substances is essential to deter abuse, stakeholders caution that overly restrictive measures might stifle important advancements in drug development. Additionally, critics express concerns over the practical implications of the timeline for the implementation of new regulations, which may affect how quickly researchers can pivot to address changing substances in the market. Thus, while the bill has broad support, its practical execution and impact on research timelines remain pivotal issues in the ongoing discourse.
Related
Providing for consideration of the bill (H.R. 884) to prohibit individuals who are not citizens of the United States from voting in elections in the District of Columbia and to repeal the Local Resident Voting Rights Amendment Act of 2022; providing for consideration of the bill (H.R. 2056) to require the District of Columbia to comply with federal immigration laws; providing for consideration of the bill (H.R. 2096) to restore the right to negotiate matters pertaining to the discipline of law enforcement officers of the District of Columbia through collective bargaining, to restore the statute of limitations for bringing disciplinary cases against members or civilian employees of the Metropolitan Police Department of the District of Columbia, and for other purposes; and providing for consideration of the bill (S. 331) to amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and for other purposes.
Expressing the sense of the House of Representatives that illicit fentanyl-related substances are a weapon of mass destruction and should be classified as such, and recognizing President Trump's efforts to mitigate illicit narcotics from entering the United States through such actions as signing an Executive Order "Designating Fentanyl as a Weapon of Mass Destruction" and declaring the crisis caused by the rise of fentanyl a national health emergency.
Stopping Overdoses of Fentanyl Analogues ActThis bill permanently adds fentanyl-related substances to schedule I of the Controlled Substances Act. (A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.)Fentanyl-related substances are currently regulated under schedule I through a temporary order issued by the Drug Enforcement Administration. The temporary order expires March 31, 2025.
Adding and removing certain substances in schedules I, III and IV of the uniform controlled substances act and making conforming changes to the criminal code definition of fentanyl-related controlled substances.
Adding and removing certain substances in schedules I, III and IV of the uniform controlled substances act and making conforming changes to the criminal code definition of fentanyl-related controlled substance.